Clinical Trial Update: Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing stereotactic body radiotherapy to conventional radiotherapy in medically inoperable non-small cell lung cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED